United States · Funded startup

Who invested in Prime Medicine

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$5.0Mraised across 1 round since 2025, from 1 source

Latest round
Round, $5.0MAug 2025
Investors
5
See who backed them

The rounds

  1. Aug 2025
    Round$5.0M

    Source recorded

Founders and team

From Prime Medicine's own website: 2 founders, 14 on the team.

Andrew AnzaloneCo-founder and Head of Platform
David LiuCo-founder
  • Allan ReineChief Executive Officer
  • Ann LeeChief Technical Officer
  • Matthew HawrylukChief Business Officer
  • Mohammed AsmalChief Medical Officer
  • Niamh AlixChief Human Resources Officer
  • Ryan BrownChief Legal Officer
  • Svetlana MakhniChief Financial Officer
  • David SchenkeinBoard Member
  • Jeff MarrazzoExecutive Chair
  • Kaye FosterBoard Member
  • Michael KellyBoard Member
  • Robert NelsenBoard Member
  • Thomas CahillBoard Member
  • Wendy ChungBoard Member

Everyone who backed them

ARCH Venture PartnersVC firm1round
Cormorant Asset ManagementPrivate equity1round
Redmile GroupVC firm1round
Casdin CapitalVC firm1round
Samsara BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Prime Medicine

Who invested in Prime Medicine?

Prime Medicine's investors include ARCH Venture Partners, Cormorant Asset Management, Redmile Group, Casdin Capital and Samsara BioCapital.

How much has Prime Medicine raised?

Prime Medicine has raised $5.0M across 1 round since 2025.

When did Prime Medicine last raise?

Prime Medicine's most recent round was an Undisclosed round of $5.0M in Aug 2025.

What was Prime Medicine's biggest round?

Its most recent round, $5.0M in Aug 2025, is also its largest on record.

Who backed Prime Medicine first?

Prime Medicine's first round on record, in Aug 2025, was backed by ARCH Venture Partners, Cormorant Asset Management and Redmile Group and 2 others.

What stage is Prime Medicine at?

Prime Medicine's latest named round is an Undisclosed round, in Aug 2025.

Where is Prime Medicine based?

Prime Medicine is based in the United States.

Companies like Prime Medicine

In the same sector, and raised in the last eighteen months.

Star Therapeutics$325M · Oct 2026Promaxo$106M · Oct 2026Prolific Machines$105M · Oct 2026IMIO$19M · Oct 2026Clinical Ink$24M · Oct 2026Rejuvenate Bio$13M · Oct 2026

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app